ARBOR

engineered nucleic acid sequences for medical purposes; nucleases, fusion proteins, RNAs and biomolecular complexes for modification of cellular genome; gene editing agents for modifying RNA sequences; gene editing agents for modifying DNA sequences at genomic target sites; engineered biomolecular complexes comprised of fusion proteins and RNAs used for modifying nucleic acid sequences in human genomes; engineered biomolecular compound for enhanced regulation and correction of gene expression and mutations, excision and insertion of DNA sequences, and delivery of whole genes and nucleic acid sequences to target sites; gene therapy and cell therapy products in the nature of DNA editing complexes targeting genomic sites

custom biomanufacturing of gene editing complexes; custom biomanufacturing of engineered fusion proteins and nucleic acids for use in Cell and Gene Therapy (CGT)

bioengineering of proteins, nucleic acids, RNAs, and gene editing complexes used in genomic engineering; providing medical scientific research information in the fields of gene editing technologies and genomic engineering